Assessment of compounded transdermal mirtazapine as an appetite stimulant in cats with chronic kidney disease

OBJECTIVES: The aim of this study was to assess the appetite stimulation properties of compounded transdermal mirtazapine (CTM) in cats with chronic kidney disease (CKD). METHODS: Two sequential double-blind placebo-controlled crossover prospective studies were performed in client-owned cats with st...

Descripción completa

Detalles Bibliográficos
Autores principales: Quimby, Jessica M, Benson, Kellyi K, Summers, Stacie C, Saffire, Ashlie, Herndon, Andrea K, Bai, Shasha, Gustafson, Daniel L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099811/
https://www.ncbi.nlm.nih.gov/pubmed/31161850
http://dx.doi.org/10.1177/1098612X19851303

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099811/
https://www.ncbi.nlm.nih.gov/pubmed/31161850
http://dx.doi.org/10.1177/1098612X19851303

Ejemplares similares